We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

Congress Poised To Pass Sweeping Law Covering FDA And NIH

NPR and WBUR, November 29, 2016. NCHR President, Diana Zuckerman, says she’s concerned that the 21st Century Cures act will make it even easier for drug companies to use the express lane for approval.

Lawmakers Try for Year-End Bill on Medical Research, Devices and Opioid Addiction

Wall Street Journal, November 30, 2016. Negotiators still need to hammer out agreement in some areas, including GOP proposals for limiting FDA regulation.

Patients Increasingly Influence the Direction of Medical Research

NPR, November 28, 2016. “The bad news is that so much of patient input is involving patients who are working with or who are recruited by drug companies,” cautions NCHR’s Diana Zuckerman.

A Frenzy of Lobbying on 21st Century Cures

Kaiser Health News, November 28, 2016. Beyond the pharmaceutical industry, the bill’s supporters include universities, medical schools and groups representing them, as well as patient groups funded by drug and device companies. “It really is a David and Goliath issue of where the money is,” NCHR president Diana Zuckerman said.

Consumer Groups Caution Dems on ‘Cures’ Bill

The Hill, November 28, 2016. NCHR president Diana Zuckerman said the bill “makes it much easier to get FDA approval for things that may not work and may not be safe.”